Jinhe Biotechnology (002688.SZ) plans to invest 550 million yuan to build a project for the flexible production of 10,000 tons of lovastatin and 20,000 tons of coenzyme Q10 intermediates per year.

Zhtng Cijng APP news, Jinhe Biological (002688.SZ) announced that the company plans to invest in the construction project of a flexible production facility for the annual production of 10,000 tons of cyclosporin and 20,000 tons of coenzyme Q10 intermediates. The project is expected to have a total investment of 550 million yuan, with funding coming from the company's own funds or self-raised funds. The implementation of the project will help the company cultivate new profit growth points, enhance the overall profitability of the company, further strengthen the company's core competitiveness, improve the overall economic efficiency of the company, and align with the company's medium and long-term strategic planning.